Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    PLAT-01
Show Display Options
Rank Status Study
1 Active, not recruiting A Pediatric Trial of Genetically Modified Autologous T Cells Directed Against CD19 for Relapsed CD19+ Acute Lymphoblastic Leukemia
Condition: B Cell Leukemia
Intervention: Biological: Autologous CD19 CAR+ EGFTt + T cells

Study has passed its completion date and status has not been verified in more than two years.